Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours.
Froeling FEM, Ramaswami R, Papanastasopoulos P, Kaur B, Sebire NJ, Short D, Fisher RA, Sarwar N, Wells M, Singh K, Ellis L, Horsman JM, Winter MC, Tidy J, Hancock BW, Seckl MJ.
Froeling FEM, et al. Among authors: wells m.
Br J Cancer. 2019 Mar;120(6):587-594. doi: 10.1038/s41416-019-0402-0. Epub 2019 Feb 22.
Br J Cancer. 2019.
PMID: 30792530
Free PMC article.